Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boceprevir-response Guided Therapy in HIV/HCV Genotype 1 Co-infected Patients
NCT01718301Phase 3Terminated
- Start
- Mar 2013
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of boceprevir in hepatitis C (HCV). Started Mar 2013; status: terminated.
02
Drugs
boceprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01718301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01718301.